Company Filing History:
4 out of 6,662 
1 out of 4 
1 out of 480 
Years Active: 1996-2002
Title: Matthias Mag: Innovator in Oligonucleotides and Polyvinyl Acetals
Introduction
Matthias Mag is a notable inventor based in Oberursel, Germany. He has made significant contributions to the fields of biotechnology and materials science. With a total of 6 patents, his work focuses on innovative solutions for medical and industrial applications.
Latest Patents
One of his latest patents is titled "Stabilized oligonucleotides and their use." This invention relates to novel stabilized oligonucleotides in which at least one non-terminal pyrimidine nucleoside is modified. These oligonucleotides are intended for use as diagnostics or pharmaceuticals for treating viral infections, cancer, or diseases involving integrins or cell-cell adhesion receptors. Another significant patent is "Aqueous polyvinyl acetal dispersions." This invention describes aqueous dispersions of carboxyl-containing polyvinyl acetals that contain no emulsifiers, readily volatile organic solvents, or nonvolatile plasticizers. These dispersions are suitable as coating compositions for paper and textiles and as binders for paints and varnishes.
Career Highlights
Throughout his career, Matthias Mag has worked with prominent companies, including Hoechst Aktiengesellschaft. His experience in these organizations has contributed to his expertise in developing innovative products and technologies.
Collaborations
Matthias has collaborated with notable coworkers such as Joachim Engels and Mathias Herrlein. These partnerships have likely enhanced his research and development efforts.
Conclusion
Matthias Mag is a distinguished inventor whose work in stabilized oligonucleotides and polyvinyl acetals has the potential to impact various industries significantly. His contributions reflect a commitment to innovation and excellence in his field.